FSD Pharma shares are trading higher after the company entered into an exclusive option agreement with the University of Southern California to evaluate dietary supplement technology for commercialization.
Portfolio Pulse from Benzinga Newsdesk
FSD Pharma shares are trading higher after the company entered into an exclusive option agreement with the University of Southern California to evaluate dietary supplement technology for commercialization.
June 13, 2024 | 11:35 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
FSD Pharma (HUGE) shares are trading higher following an exclusive option agreement with the University of Southern California to evaluate dietary supplement technology for commercialization.
The exclusive option agreement with a reputable institution like USC is likely to boost investor confidence in FSD Pharma's potential for innovation and commercialization in the dietary supplement market, leading to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100